analiza aiqbench
scDEFT introduces a novel deep learning framework that leverages longitudinal single-cell atlases to predict drug response and explain patient divergence through counterfactual reasoning. By treating drugs as conditioning operators on cell representations, the model achieves significant stratification accuracy in inflammatory bowel disease cohorts where standard predictors fail. This work advances the intersection of machine learning and precision medicine by enabling mechanistic insights into therapeutic effects at single-cell resolution.
scDEFT: A deep learning framework for drug-effect prediction and counterfactual reasoning
arXiv:2609.10831v1 Announce Type: cross Abstract: Longitudinal single cell atlases now capture matched pre treatment and post treatment states from responders and non responders, presenting an opportunity to mechanistically explain why two patients on the same drug diverge. We introduce scDEFT (single cell Drug EFfect Transducer), which treats a drug as a conditioning operator on cell representations, enabling prediction and explanation. In scDEFT, feature wise linear modulation produces drug conditioned cell latents, learned under abundant per cell supervision and then frozen. Two independent heads aggregate those latents over shared transcriptional neighborhoods to predict drug induced state change and responder status. A backward stage ranks the latent dimensions by how strongly they separate responders from non responders and maps them to genes under a cell composition control. On a harmonized inflammatory bowel disease atlas of 1.16 million cells, three cohorts and two drug classes, scDEFT predicts state change at 45% of the baseline to reproducibility ceiling headroom and stratifies responders before treatment at AUROC 0.70, where standard predictors remain at chance. These predictions and the drivers behind them support target and co target nomination, patient stratification, and counterfactual prediction of unseen drug cohort effects.
Abstract:Longitudinal single cell atlases now capture matched pre treatment and post treatment states from responders and non responders, presenting an opportunity to mechanistically explain why two patients on the same drug diverge. We introduce scDEFT (single cell Drug EFfect Transducer), which treats a drug as a conditioning operator on cell representations, enabling prediction and explanation. In scDEFT, feature wise linear modulation produces drug conditioned cell latents, learned under abundant per cell supervision and then frozen. Two independent heads aggregate those latents over shared transcriptional neighborhoods to predict drug induced state change and responder status. A backward stage ranks the latent dimensions by how strongly they separate responders from non responders and maps them to genes under a cell composition control. On a harmonized inflammatory bowel disease atlas of 1.16 million cells, three cohorts and two drug classes, scDEFT predicts state change at 45% of the baseline to reproducibility ceiling headroom and stratifies responders before treatment at AUROC 0.70, where standard predictors remain at chance. These predictions and the drivers behind them support target and co target nomination, patient stratification, and counterfactual prediction of unseen drug cohort effects.
21 Pages, 5 Figures, 3 Tables, and a Supplementary Notes section for overflow material. Approximately 3000 words (excluding Figures, Tables, and Captions)
Quantitative Methods (q-bio.QM); Machine Learning (cs.LG)
arXiv:2609.10831 [q-bio.QM]
(or arXiv:2609.10831v1 [q-bio.QM] for this version)
https://doi.org/10.48550/arXiv.2609.10831 arXiv-issued DOI via DataCite (pending registration)
Text integral sub licența deschisă a publicației · 230 cuvinte
Subiecte conexe

Deconfusing Corrigibility
AI Alignment Forum · 17 oct. 2026

The Entangled Dimensions of Decision Theory
LessWrong · 30 iul. 2026

BRICS Draws a New Global Line: Full Text of New Delhi Declaration
slguardian.org · 12 sept. 2026

AI in healthcare: applications and best practices
Databricks · 24 iul. 2026